by plexusventures_h3tnl0 | Nov 30, 2017 | Uncategorized
Plexus Ventures would like to share successful news from Celon Pharma. Additional details are provided in Celon’s press release (Warsaw, 30.11.2017): • Finalisation of the DCP opens new perspectives for the Company in terms of export to the market as big as approx. 3...
by plexusventures_h3tnl0 | Aug 17, 2017 | Uncategorized
Philadelphia, PA – Plexus Ventures, a global pharmaceutical consulting firm, announces its collaboration with Celon Pharma SA, Łomianki, Poland. Michael O’Sullivan Managing Partner London Office, noted: “We are very pleased to provide continuing support to an...
by plexusventures_h3tnl0 | Jun 13, 2017 | Uncategorized
Philadelphia, Pennsylvania – Plexus Ventures is pleased to announce it assisted the successful completion of a transaction in which Vendis Capital, a European private equity fund specialized in the consumer brands sector, invested in Sylphar, a fast-growing,...
by plexusventures_h3tnl0 | May 22, 2017 | Uncategorized
Philadelphia, PA – Plexus Ventures is pleased to announce that its client, Fujifilm Kyowa Kirin Biologics (FKB), has confirmed that the European Medicines Agency (EMA) has accepted for review the Marketing Authorization Application for FKB327 (adalimumab biosimilar)....
Recent Comments